# Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)

> **NCT01487499** · PHASE3 · TERMINATED · sponsor: **University of Florida** · enrollment: 4 (actual)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01487499
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Unable to enroll adequate number of participants
- **Last updated:** 2015-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01487499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01487499, "Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01487499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*